Last reviewed · How we verify

Dental foam "Biorepair PERIBIOMA"

I.M. Sechenov First Moscow State Medical University · FDA-approved active Small molecule

Biorepair PERIBIOMA is a dental foam that delivers bioactive microparticles to promote periodontal tissue regeneration and repair.

Biorepair PERIBIOMA is a dental foam that delivers bioactive microparticles to promote periodontal tissue regeneration and repair. Used for Periodontal disease treatment and tissue regeneration, Periodontal pocket therapy.

At a glance

Generic nameDental foam "Biorepair PERIBIOMA"
SponsorI.M. Sechenov First Moscow State Medical University
Drug classDental biomaterial/tissue regeneration product
ModalitySmall molecule
Therapeutic areaDentistry/Periodontics
PhaseFDA-approved

Mechanism of action

The foam formulation contains microparticles designed to support the regeneration of periodontal tissues damaged by disease or inflammation. It works by creating a biocompatible matrix that facilitates tissue healing and may promote the growth of periodontal ligament and bone cells in the periodontal pocket.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: